Related Experiment Video

Updated: Jun 17, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment

Débora Rosa Bublik1, Massimiliano Scolz, Gianluca Triolo

  • 1Laboratorio Nazionale del Consorzio Interuniversitario per le Biotecnologie, International Centre for Genetic Engineering and Biotechnology, Area Science Park, Padriciano 99, 34149 Trieste, Italy.

The Journal of Biological Chemistry
|December 19, 2009
PubMed

Insights

Human GTSE-1 protein stabilizes p21 levels by preventing degradation, crucial for cell cycle control and paclitaxel resistance. This discovery reveals a new mechanism for regulating cell cycle inhibitors.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • p21(CIP1/WAF1) is a key cell cycle regulator from the CIP/KIP family of Cdk inhibitors.
  • Its expression is tightly controlled by transcriptional and post-translational mechanisms, vital for cell cycle progression and stress response.

Purpose of the Study:

  • To identify novel mechanisms regulating p21(CIP1/WAF1) levels.
  • To investigate the role of human GTSE-1 (G(2) and S phase-expressed-1) in p21(CIP1/WAF1) regulation.

Main Methods:

  • Investigated the interaction between hGTSE-1 and p21(CIP1/WAF1).
  • Assessed the effect of hGTSE-1 on p21(CIP1/WAF1) stability and proteasomal degradation.
  • Utilized cell-based assays to evaluate the functional consequences of hGTSE-1 mediated p21(CIP1/WAF1) stabilization.

Main Results:

  • Demonstrated that hGTSE-1 protects p21(CIP1/WAF1) from proteasome-dependent degradation.
  • Identified a functional complex involving hGTSE-1, WISp39, and Hsp90 that stabilizes p21(CIP1/WAF1).
  • Showed that the N-terminal portion of hGTSE-1 is sufficient for binding and stabilizing p21(CIP1/WAF1).

Conclusions:

  • hGTSE-1 represents a novel regulator of p21(CIP1/WAF1) stability.
  • The hGTSE-1/WISp39/Hsp90 complex plays a critical role in preventing p21(CIP1/WAF1) degradation.
  • hGTSE-1 mediated stabilization of p21(CIP1/WAF1) contributes to cellular resistance against paclitaxel-induced cytotoxicity.

More Related Videos

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...